SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,895.74 315.20
( 0.43%)

Global Indices

Nasdaq

51,839.66 468.68
(0.91%)

Dow Jones

7,763.25 38.12
(0.49%)

Hang Seng

66,308.10 794.11
(1.21%)

Nikkei 225

10,694.57 14.58
(0.14%)

Forex

USD-INR

95.89 0.16
(0.16%)

EUR-INR

109.08 -0.12
(-0.11%)

GBP-INR

126.82 -0.30
(-0.24%)

JPY-INR

0.60 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indoco Remedies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532612

INE873D01024

119.0843544

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INDOCO

108.99

2344.05

EPS(TTM)

Face Value()

Div & Yield %

2.33

0.08

Back

asian paints ltd

Carysil consolidated net profit rises 37.73% in the June 2026 quarter

Aug 10,2026

Net profit of Carysil rose 37.73% to Rs 31.43 crore in the quarter ended June 2026 as against Rs 22.82 crore during the previous quarter ended June 2025. Sales rose 15.49% to Rs 262.14 crore in the quarter ended June 2026 as against Rs 226.99 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	262.14	226.99	15
OPM %	20.37	19.32	-
PBDT	52.69	39.77	32
PBT	42.12	30.33	39
NP	31.43	22.82	38

73,895.74 315.20 ( 0.43%)

51,839.66 468.68 (0.91%)

7,763.25 38.12 (0.49%)

66,308.10 794.11 (1.21%)

10,694.57 14.58 (0.14%)

95.89 0.16 (0.16%)

109.08 -0.12 (-0.11%)

126.82 -0.30 (-0.24%)

0.60 0.00 (-0.20%)